What is Neocis?
Neocis, Inc. is a Miami, Florida-based private company revolutionizing dental surgery through advanced robotics. Its flagship product, Yomi®, is the first and only robot-assisted surgical platform for the dental industry that has received clearance from the U.S. Food and Drug Administration. The company's vision is to advance healthcare by integrating cutting-edge technology into surgical procedures, aiming to enhance precision and patient outcomes in dentistry.
How much funding has Neocis raised?
Neocis has raised a total of $178.3M across 6 funding rounds:
Series B
$1.3M
Private Equity
$15M
Series C
$30M
Series D
$72M
Other Financing Round
$40M
Other Financing Round
$20M
Series B (2014): $1.3M, investors not publicly disclosed
Private Equity (2017): $15M, investors not publicly disclosed
Series C (2019): $30M supported by Mithril Capital Management and Norwest Venture Partners
Series D (2020): $72M featuring Mithril Capital Management, Fred Moll, Section 32, Draper Associates, Norwest Venture Partners, and Vivo Capital
Other Financing Round (2022): $40M backed by Mithril Capital Management, DFJ Growth, Intuitive Ventures, Norwest Venture Partners, and Vivo Capital
Other Financing Round (2024): $20M with participation from NVentures and Mirae Asset Capital Markets (India) Pvt
Key Investors in Neocis
Mithril Capital Management
Mithril Capital Management is a long-term venture capital fund focused on investing in technology-driven businesses ripe for transformation across various sectors. They partner with teams leveraging technology to build enduring companies.
Norwest Venture Partners
Norwest Venture Partners is a global multi-stage venture capital and growth equity firm with a long history dating back to 1961, investing in a wide range of companies.
NVentures
NVentures is an upstream exploration firm providing technical and commercial intelligence for the E&P and Energy industry, with a growing focus on hydrogen and renewables.
What's next for Neocis?
With substantial backing, Neocis is poised for accelerated expansion and further innovation in robotic dental surgery. The recent major strategic investment suggests a focus on scaling operations, enhancing Yomi®'s capabilities, and potentially broadening its market reach. Future developments are likely to center on refining the robotic platform, expanding its applications within dentistry, and solidifying its position as a leader in a rapidly evolving MedTech landscape. The company's trajectory indicates a strong commitment to leveraging technology for significant advancements in surgical care.
See full Neocis company page
